The content discussed and opinions expressed are those of the speakers only, and do not necessarily reflect the position of Roche.
The content of this video may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your country. Providing this scientific information should not be construed as a recommendation to use or prescribe such compounds.
Prescribing information may vary depending on the applicable approval in the respective country. Therefore, before prescribing any product, always refer to applicable local materials such as the prescribing information and/or the Summary of Product Characteristics (SmPC).
The EU SmPC for ocrelizumab is available here.
© 2024 F. Hoffmann-La Roche Ltd. All trademarks mentioned herein are protected by law. www.roche.com.
M-XX-00019125, October 2024